Skip to content

MDMA research published in 2020

Page 2 of 4: studies 21 to 40 of 66, newest first. Back to the MDMA overview

Studies

Use characteristics and harm potential of ecstasy in The Netherlands

Drugs Education Prevention and Policy September 10, 2020 Jan Van Amsterdam, Johannes G. Ramaekers, Ton Nabben et al. 4 citations

Introduction Ecstasy (MDMA) is a popular recreational drug, but its illegal production and trade in the Netherlands have developed into a serious public order and ecological problem which endanger and question the harm reduction approach of the Dutch ecstasy policy.Methods The market characteristics, adverse health effects, risk profile, and link to criminal activity of ecstasy were...

Differential sensitivity to detect prosocial effects of 3,4‐methylenedioxymethamphetamine (MDMA) in different social approach paradigms in mice

Neuropsychopharmacology Reports September 1, 2020 Satoko Mukai, Sao Nakada, Hikari Kamada et al.

AbstractA recreational drug, 3,4‐methylenedioxymethamphetamine (MDMA), has prosocial effects including increased sociability, enhancement of trust feelings, and empathy. Although several methods, such as the social interaction and three chamber tests, have been used, the neural mechanisms underlying the prosocial effects have not been well understood. In the present study, based on a social...

Regional changes in ∆FosB expression in rat brain following MDMA self‐administration predict increased sensitivity to effects of locally infused MDMA

Addiction Biology September 1, 2020 Ross Van de Wetering, Susan Schenk 9 citations

AbstractRepeated exposure to drugs produces a plethora of persistent brain changes, some of which underlie the development of drug addiction. An important objective of addiction research is to identify the brain changes that might mediate the transition from drug use to drug misuse. The persistent accumulation of the transcription factor, ∆FosB, following repeated drug exposure provides a means...

Patterns of ecstasy use amongst live music event attendees and their opinions on pill testing: a cross sectional study.

Substance Abuse Treatment, Prevention, and Policy August 5, 2020 Madeleine Southey, Ashwini Kathirgamalingam, Benjamin Crawford et al.

Pill testing services could potentially be used to reduce drug-related harm. This study aims to identify patterns of ecstasy use among live music event attendees; explore the opinions and potential usage of illicit pill testing programs and examine factors associated with the likelihood of still taking a pill containing a potential harmful substance. A cross-sectional survey was completed by...

The impact of 3,4-methylendioxymetamphetamine (MDMA) abstinence on seeking behavior and the expression of the D2-like and mGlu5 receptors in the rat brain using saturation binding analyses.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society August 2020 Małgorzata Frankowska, Joanna Miszkiel, Lucyna Pomierny-Chamioło et al.

The abundance of research indicates that enriched environment acts as a beneficial factor reducing the risks of relapse in substance use disorder. There is also strong evidence showing the engagement of brain dopaminergic and glutamatergic signaling through the dopamine D2-like and metabotropic glutamate type 5 (mGlu5) receptors, respectively, that has a direct impact on drug reward and drug...

Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials.

Psychopharmacology August 1, 2020 Lisa Jerome, Allison A. Feduccia, Julie B. Wang et al. 163 citations Retracted

Posttraumatic stress disorder (PTSD) is a chronic condition that has wide-ranging negative effects on an individual's health and interpersonal relationships. Treatments with long-term benefits are needed to promote the safety and well-being of those suffering from PTSD. To examine long-term change in PTSD symptoms and additional benefits/harms after 3,4-methylenedioxymethamphetamine...

Comparative Untargeted Metabolomics Analysis of the Psychostimulants 3,4-Methylenedioxy-Methamphetamine (MDMA), Amphetamine, and the Novel Psychoactive Substance Mephedrone after Controlled Drug Administration to Humans

Metabolites July 27, 2020 Andrea E. Steuer, Daria Kaelin, Martina I. Boxler et al. 32 citations

Psychoactive stimulants are a popular drug class which are used recreationally. Over the last decade, large numbers of new psychoactive substances (NPS) have entered the drug market and these pose a worldwide problem to human health. Metabolomics approaches are useful tools for simultaneous detection of endogenous metabolites affected by drug use. They allow identification of pathways or...

Perceived harm, motivations for use and subjective experiences of recreational psychedelic ‘magic’ mushroom use

Journal of Psychopharmacology July 17, 2020 Carl A Roberts, Isaac Osborne-Miller, Jon C. Cole et al. 33 citations

Background: Data on actual harm of magic mushrooms suggest that toxicity and abuse potential is low, however, their legal status suggests otherwise. We aimed to gauge perception of harm of magic mushrooms in both users and mushroom-naïve participants. We also aimed to observe differences in expectations of effects between users and mushroom-naïve participants, and whether motivations for use...

Enhancement of the rewarding effects of 3,4-methylenedioxymethamphetamine in orexin knockout mice.

Behavioural Brain Research July 9, 2020 Tomohisa Mori, Naoki Uzawa, Daiki Masukawa et al.

Orexinergic neurons, which are closely associated with narcolepsy, regulate arousal and reward circuits through the activation of monoaminergic neurons. Psychostimulants as well as 5-HT-related compounds have potential in the treatment of human narcolepsy. Previous studies have demonstrated that orexin receptor antagonists as well as orexin deficiencies affect the pharmacological effects of...

Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment

Frontiers in Psychiatry July 7, 2020 Michael Specka, Thomas Kuhlmann, Jürgen Sawazki et al. 42 citations

Background About 15 years ago, a diverse group of new recreational psychotropic substances began to emerge, which were marketed for example as “legal highs,” “research chemicals,” or “designer drugs.” These substances were later subsumed under the label “Novel Psychoactive Substances” (NPS). Important NPS classes are cathinones, synthetic cannabimimetics, phenethylamines, and herbal drugs. The...

Methylenedioxymethamphetamine-like discriminative stimulus effects of pyrrolidinyl cathinones in rats

Journal of Psychopharmacology July 1, 2020 Michael B. Gatch, Michael J Forster

Background: Synthetic cathinone derivatives are used as alternatives both for stimulant drugs such as cocaine and methamphetamine and for club drugs such as 3,4-methylenedioxymethamphetamine (MDMA), but little is known about their MDMA-like subjective effects. Methods In order to determine their similarity to MDMA, the discriminative stimulus effects of 10 pyrrolidinyl cathinones...

A proof-of-principle study of the short-term effects of 3,4-methylenedioxymethamphetamine (MDMA) on tinnitus and neural connectivity.

International Journal of Neuroscience July 2020 G D Searchfield, T N E R Poppe, M Durai et al.

Background: This study was conducted to investigate the short-term behavioural and neurophysiological effects of 3,4-methylenedioxymethamphetamine (MDMA) on tinnitus perception.Methods: A double-blind randomized controlled cross-over design. Part 1. Behavioural measures of tinnitus following 30 mg MDMA or placebo administration (N = 5 participants) and Part 2. Behavioural measures of tinnitus...

DOI: 10.1080/00207454.2019.1702544 (opens in new tab) Full text (opens in new tab) 3,4-methylenedioxymethamphetamine Tinnitus Rs-MRI Treatment

Effect of duloxetine acute treatment against 3, 4 methylenedioxymethamphetamine-induced cognitive impairment and memory deficiency in male rats

Avicenna Journal of Neuro Psycho Physiology June 22, 2020

Background and Aims: 3, 4- methylenedioxymethamphetamine (MDMA) is used for recreational purposes worldwide. The use of MDMA resulted in learning and memory dysfunction. Duloxetine, a serotonin/noradrenalin-reuptake inhibitor is also utilized to treat depression and anxiety. The current study aimed to evaluate the effects of duloxetine against MDMAchr('39')s effect on anxiety, cognition, and...

Use of the CytoSorb adsorption device in MDMA intoxication: a first-in-man application and in vitro study

Intensive Care Medicine Experimental June 21, 2020 Corinna N. Lang, Michaela J. Sommer, Merja A. Neukamm et al. 31 citations

Abstract Background 3,4-Methylenedioxymethamphetamine (MDMA, “ecstasy”) abuse is frequent, and overdosing might cause severe and eventually lethal multi-organ failure. To date, there is no causal therapy of MDMA intoxication and removal of MDMA from the circulation might be a reasonable measure to prevent adverse courses after overdosing. We present here first-in-man experience and in vitro...

Acute effects of MDMA on trust, cooperative behaviour and empathy: A double-blind, placebo-controlled experiment.

Journal of Psychopharmacology June 15, 2020 Anna Borissova, Bart Ferguson, Matthew B. Wall et al. 37 citations

BACKGROUND: 3,4-Methylenedioxymethamphetamine (MDMA) is being actively researched as an adjunct to psychotherapy. It may be beneficial to trust, empathy and cooperative behaviour due to its acute prosocial effects. AIM: To test (a) the acute effects of MDMA on measures of empathy, trust and cooperative behaviour, and (b) subacute changes in mood three days after MDMA administration. METHODS: =7...

DOI: 10.1177/0269881120926673 (opens in new tab) Full text (opens in new tab) MDMA Effects MDMA Research MDMA Study MDMA Findings +21

Sexual Risk Behaviors among African Americans Who Use MDMA (Molly/Ecstasy): Implications for HIV Prevention.

Social work in public health June 1, 2020 Khary K. Rigg, Alexandra Mills

Numerous studies have linked sexual risk taking to recreational use of MDMA. Questions remain, however, regarding the extent and type of sexual risk behaviors that occur among MDMA users, especially African Americans who use the drug. Because the MDMA literature has historically relied on samples with little minority representation, little is known about Black MDMA users and their sexual risk...

Methylenedioxymethamphetamine-like discriminative stimulus effects of seven cathinones in rats

Behavioural Pharmacology June 1, 2020 Michael B. Gatch, Sean B. Dolan, Michael J. Forster 6 citations

Synthetic cathinone derivatives are commonly considered quasi-legal alternatives for stimulant drugs, such as cocaine and methamphetamine, but some derivatives are increasingly being detected in club drug formulations of Ecstasy or ‘Molly’ as substitutes for methylenedioxymethamphetamine (±-MDMA). Although several studies have evaluated the psychostimulant-like effects of synthetic cathinones,...

MDMA-assisted psychotherapy for people diagnosed with treatment-resistant PTSD: what it is and what it isn’t

Annals of General Psychiatry May 17, 2020 Louise Morgan 27 citations

Abstract Background PTSD is a chronic condition with high rates of comorbidity, but current treatment options are limited and not always effective. One novel approach is MDMA-assisted psychotherapy for people diagnosed with treatment-resistant PTSD, where MDMA is used as a catalyst to facilitate trauma processing during psychotherapy. The aim was to review all current research into...

DOI: 10.1186/s12991-020-00283-6 (opens in new tab) Full text (opens in new tab) Posttraumatic stress disorder Treatment-Resistant PTSD MDMA-Assisted Psychotherapy

Data justify further research on potential of psychedelics in treating psychiatric disorders

The Brown University Psychopharmacology Update May 6, 2020 1 citation

Although research findings to date do not support the use of psychedelic compounds in the treatment of psychiatric disorders, the existing body of research justifies continued investigation, a literature review concludes. The review found the most significant evidence supporting use of psilocybin and 3,4‐methylenedioxymethamphetamine (MDMA). Both of these drugs have been given “breakthrough...

High ambient temperature increases the toxicity and lethality of 3,4-methylenedioxymethamphetamine and methcathinone.

Pharmacology, Biochemistry, and Behavior May 2020 Yu Chen, Huyen T N Tran, Yasir H Saber et al.

Methylenedioxymethamphetamine (MDMA) and methcathinone (MCAT) are abused psychostimulant drugs that produce adverse effects in human users that include hepatotoxicity and death. Recent work has suggested a connection between hepatotoxicity, elevations in plasma ammonia, and brain glutamate function for methamphetamine (METH)-induced neurotoxicity. These experiments investigated the effect of...